icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
14 Jan, 2021 12:44

Sputnik V takes off, but not for all: Residents in half of Russian regions have no access to Covid-19 vaccine, research reveals

Sputnik V takes off, but not for all: Residents in half of Russian regions have no access to Covid-19 vaccine, research reveals

Experts from St. Petersburg have discovered that the general public in almost half of all Russian regions has no access to Covid-19 vaccines, with just five of the country’s 85 federal subjects reporting ‘high’ availability.

The research by the Petersburg Politics Foundation – which excludes vaccination of priority groups like the military, doctors, and teachers – puts the “unevenness of access” down to the “lobbying abilities” of each individual region.
Of the 42 areas where it is impossible to register for a vaccine, some have reported receiving limited quantities, which were given directly to the highest risk groups. An additional eight regions are pre-registering those interested, despite having no current availability.

Also on rt.com Western media has spent months bashing Russia’s Sputnik V vaccine, but now its Moscow correspondents lining up for Covid-19 jabs

The five areas with high availability were named as Moscow and its surrounding region, Sakhalin Region, Nenets Autonomous District, and Chukotka Autonomous District. Excluding Moscow Region, these are some of the wealthiest regions in the country (per person).

The numbers were part of a report detailing the successes and difficulties of Sputnik V, the first approved Russian vaccine. In particular, the foundation noted how it had overcome most of its “repetitional crisis.” It also pointed out that the initial reluctance to be vaccinated helped prevent demand from outstripping supply, especially from those who were apprehensive about receiving it before the end of clinical trials. Media rumors about a 42-day alcohol abstinence period following vaccination also helped lower demand.

Also on rt.com Science wins: Russia’s ‘top-league’ Sputnik V coronavirus jab should be ‘priority choice’ due to safety, health expert tells RT

As for difficulties, the report pointed the finger at a lack of joined-up thinking throughout the country, with each individual region having different priorities for who should receive the vaccine, as well as inconsistency in reporting.

“The problems are still the unavailability of statistics for individual regions and the inconsistency of its interpretation,” it said. "For example, in some cases, the number of doses is understood as the number of individual shots per person, in others – at the rate of 1 person – 2 doses.”

On August 11, President Vladimir Putin announced that Russia had registered the world’s first Covid-19 vaccine, Sputnik V, developed by Moscow’s Gamaleya Institute for Epidemiology and Microbiology. On Wednesday, Putin ordered mass vaccination to begin throughout the country.

If you like this story, share it with a friend!